Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Approaches in HFpEF: MicroRNAs and iPSC-Derived Cardiomyocytes.

Journal of cardiovascular translational research - 1 Jun 2017

Kriegel Alison J, Gartz Melanie, Afzal Muhammad Z, de Lange Willem J, Ralphe J Carter, Strande Jennifer L

Abstract excerpt

Heart failure with preserved left ventricular ejection fraction (HFpEF) has emerged as one of the largest unmet needs in cardiovascular medicine. HFpEF is increasing in prevalence and causes significant morbidity, mortality, and health care resource utilization. Patients have multiple co-morbidities which contribute to the disease complexity. To date, no effective treatment for HFpEF has been identified. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line
Share to Gene Expression Regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heart Failure

Share to Induced Pluripotent Stem Cells

Share to MicroRNAs

Share to Myocytes, Cardiac

Share to Signal Transduction

Share to Stroke Volume

Source

Open in PubMed Open full text

Identifiers

PMID: 28032312
DOI: 10.1007/s12265-016-9723-z
PMCID: PMC5937699

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Approaches in HFpEF: MicroRNAs and iPSC-Derived Cardiomyocytes.PMID 28032312Read ↗

Pathophysiological understanding of HFpEF: microRNAs as part of the puzzle.Semantic proximity Read ↗

Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes.Semantic proximity Read ↗

Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and ChallengesSemantic proximity Read ↗

Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes.Semantic proximity Read ↗

New Insights into the Functions of MicroRNAs in Cardiac Fibrosis: From Mechanisms to Therapeutic StrategiesSemantic proximity Read ↗

Human Induced Pluripotent Stem Cells as a Disease Model System for Heart FailureSemantic proximity Read ↗

Heart failure: advanced development in genetics and epigenetics.Semantic proximity Read ↗

Induced Pluripotent Stem Cells: A New Dawn for the Treatment of Ischemic CardiomyopathySemantic proximity Read ↗

Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.Semantic proximity Read ↗

Induced pluripotent stem-cell-derived cardiomyocytes: cardiac applications, opportunities, and challenges.Semantic proximity Read ↗

The Roles of Exosome-Derived microRNAs in Cardiac FibrosisSemantic proximity Read ↗

Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived CardiomyocytesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.